United States HR 2375: Preserve Access to Affordable Generics and Biosimilars Act

Status: Reported by the Committee on Judiciary. H. Rept. 116-693, Part I. (as of 2020-12-24)

State: United States · Session: 116 · Bill: HR 2375

Subjects: Administrative law and regulatory procedures, Civil actions and liability, Competition and antitrust, Congressional oversight, Contracts and agency, Federal Trade Commission (FTC), Intellectual property, Judicial review and appeals, Licensing and registrations, Marketing and advertising, Prescription drugs

Sponsors: JERROLD NADLER, David N. Cicilline, Doug Collins, Mark Meadows, Steve Cohen

View United States HR 2375 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.